KBS Research

KBS Research is a digestive health company dedicated to developing scientifically validated botanical treatments for gastrointestinal issues. The company's primary product, Atrantil, is a unique formulation of polyphenols designed to target methane-producing bacteria in the small intestine, which are a common cause of bloating and abdominal discomfort. Founded by board-certified gastroenterologist Dr. Kenneth Brown, KBS Research focuses on bridging the gap between traditional medicine and natural supplements through clinical evidence. The company's research emphasizes the role of the gut microbiome and the efficacy of specific plant-based compounds in managing conditions like Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO). KBS Research continues to expand its reach through direct-to-consumer channels and partnerships with healthcare practitioners. Its flagship product is currently available globally and is supported by peer-reviewed clinical trials.